| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 31-Mar-09 | 26-Dec-08 | | Total Revenue | 5,424 | 5,934 | 6,110 | 7,607 | | Cost of Revenue | 3,360 | 2,937 | 3,777 | 4,329 | | | Gross Profit | 2,064 | 2,997 | 2,333 | 3,278 | | | Operating Expenses | | Research Development | 1,167 | 1,063 | 1,355 | 1,112 | | Selling General and Administrative | 1,399 | 1,624 | 2,144 | 1,841 | | Non Recurring |
-
| 40 | (266) | 58 | | Others | 518 | 515 | 520 | 517 | | | | Total Operating Expenses |
-
| 3,242 | 3,753 | 3,528 | | | | Operating Income or Loss | (1,020) | (245) | (1,420) | (250) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (88) | 30 | 3 | (3) | | Earnings Before Interest And Taxes | (1,108) | (215) | (1,417) | (253) | | Interest Expense | 84 | 81 | 80 | 106 | | Income Before Tax | (1,192) | (296) | (1,497) | (359) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,192) | (296) | (1,497) | (359) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,192) | (296) | (1,497) | (359) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,192) | ($296) | ($1,497) | ($359) |
|
0.03% Nasdaq 
Income Statement
